Last reviewed · How we verify

NCT04184102: mastectomy

.Exercise and Follow-up After a Mastectomy

Completed NA Last updated 3 December 2019
What this trial tests

NA trial testing education in Mastectomy; Lymphedema in 60 participants. Completed in 30 July 2018.

Timeline
1 January 2018
Primary endpoint
1 May 2018
30 July 2018

Quick facts

Lead sponsorAmerican University of Beirut Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date1 January 2018
Primary completion1 May 2018
Estimated completion30 July 2018
Sites1 location across Lebanon

Drugs / interventions tested

Conditions studied

Sponsor

American University of Beirut Medical Center

Who can join

Adults 33 to 55, female only, with Mastectomy; Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Randomized Control Trial (RCT) on the effect of education and Exercise on women after a mastectomy found positive results in range of motion of the affected shoulder and quality of life in the intervention group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Impact of Therapeutic Exercises on the Quality of Life and Shoulder Range of Motion in Women After a Mastectomy, an RCT.
    Majed M, Neimi CA, Youssef SM, Takey KA, et al · · 2022 · cited 4× · PMID 33219500 · DOI 10.1007/s13187-020-01894-z

Verify or expand the search:

Other trials of education

Trials testing the same drug.

Other recruiting trials for Mastectomy; Lymphedema

Currently open trials in the same condition.

Other American University of Beirut Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04184102.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing